Entera Bio Ltd Cash Flow-to-Debt Ratio
Entera Bio Ltd cash flow-to-debt ratio. Entera Bio Ltd (ENTX) has a Cash Flow-to-Debt Ratio of -0.28x as of June 2026, meaning its operating cash flow of $-3.46 Million could theoretically repay 0% of its total liabilities ($12.21 Million) in one year. Check ENTX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Entera Bio Ltd (2015–2025)
Cash flow-to-debt ratio of Entera Bio Ltd from 2015 to 2025. Historical debt coverage capacity for Entera Bio Ltd across 11 annual periods. Also explore Entera Bio Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Entera Bio Ltd Cash Flow-to-Debt Ratio by Year (2015–2025)
Entera Bio Ltd cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Entera Bio Ltd. For the full cash flow conversion analysis, see Entera Bio Ltd (ENTX) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.55x | $-7.37 Million | $2.89 Million | ▲ +51.0% |
| 2024 | -5.20x | $-6.82 Million | $1.31 Million | ▲ +1.8% |
| 2023 | -5.30x | $-7.31 Million | $1.38 Million | ▲ +41.8% |
| 2022 | -9.10x | $-12.50 Million | $1.37 Million | ▼ -243.7% |
| 2021 | -2.65x | $-9.06 Million | $3.42 Million | ▲ +44.5% |
| 2020 | -4.77x | $-10.56 Million | $2.21 Million | ▼ -156.0% |
| 2019 | -1.86x | $-8.92 Million | $4.78 Million | ▲ +38.6% |
| 2018 | -3.04x | $-9.80 Million | $3.23 Million | ▼ -2909.1% |
| 2017 | -0.10x | $-4.53 Million | $44.84 Million | ▼ -1.3% |
| 2016 | -0.10x | $-3.14 Million | $31.53 Million | ▲ +18.9% |
| 2015 | -0.12x | $-3.50 Million | $28.43 Million | — |